NBSE - Why Neubase Therapeutics (NBSE) Shares Are Nosediving | Benzinga

Neubase Therapeutics Inc (NASDAQ:NBSE) shares are trading lower by 53% to $0.47 during Tuesday’s session after the company on Monday announced it is holding a Special Meeting of Stockholders on May 13, online, to discuss and vote on the proposed liquidation and dissolution of the company, along with an adjournment proposal if necessary.

The Board of Directors unanimously recommends voting in favor of these proposals, considering them beneficial for NeuBase and its stockholders. The meeting will be conducted virtually, and stockholders must register by May 12, to attend.

It’s emphasized that both attending and voting are important, and detailed instructions on how to participate and vote are provided in the accompanying proxy statement. The notice is signed by Todd Branning, Interim Chief Executive Officer ...

NBSE) Shares Are Nosediving>Full story available on Benzinga.com